Immune Deficiency Disorders
📧 Sign up to get email alerts when something new happens for Immune Deficiency Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases [Phase 1]
Phase 1 safety study of gene-modified donor T cell infusion after stem cell transplantation for non-malignant diseases has been terminated; …
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID [Phase 2, Phase 3]
Phase 2/3 trial evaluating TCR alpha/beta depletion for hematopoietic stem cell transplantation from haploidentical and unrelated donors in …
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases [Phase 3]
Phase 3 trial update reporting pharmacokinetics and safety of Subgam-VF in primary immunodeficiency diseases, including CVID, X-linked agamm…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD) [Phase 3]
Open-label Phase III trial of NABI-IGIV 10% in subjects with primary immune deficiency disorders has completed; results posted in 2012.